xarelto

January 28, 2016

A Look at Xarelto Commercials

A recent article from Digital Trends takes a look at the frequently aired Xaretlo commercial and the health issues surrounding the drug. In case you haven’t seen the commercial, which would indicate you do not watch any sporting events, and likely do not watch television at all, it stars Kevin Nealon from Saturday Night Live fame, legendary golfer Arnold Palmer, and NASCAR’s Brian Vickers all having a friendly game of golf.

As implausible as this scenario sounds, the next thing the group of close friends do is discuss how Xarelto has helped their lives. Vickers said he was diagnosed with a blood clot in his leg, and would require a blood thinning medication so he talked to his doctor about Xaretlo. He is even shown wearing a Xarelto sponsored racing uniform, though they are not actually his sponsor. It should also be noted that the fine print said Vickers had to stop racing while taking Xaretlo. Continue reading

August 9, 2015

Concern Over Dangers of Pradaxa

by Jeffrey S. Glassman

Pradaxa is one of the popular drugs that are part of a relatively new class of oral anticoagulants used to treat patients who suffer from a medical condition known as atrial fibrillation (Afib). These news drugs have been designed and marketed as better alternatives to Warfarin (Coumadin), which has been the traditional drug therapy option for Afib for many years.

While Warfarin has been proven to be effective at treating patients who suffer from Afib, patients must have their blood drawn on a very frequent basis, so their doctors can make sure the dose is correct. If the dose is not correct, Warfarin can result in serous internal bleeding disorders. There are also important dietary restrictions for patients taking Warfarin, because there are certain foods that can affect the rate at which the drug is absorbed by patients and lead to an incorrect dosage. Continue reading

July 28, 2015

New Studies Show Link Between Xarelto and Stomach Bleeding – Eye Hemorrhaging

by Jeffrey S. Glassman

Xarelto is a member of a new class of oral anticoagulant medications proscribed to patients who suffer from a serious medical condition known as atrial fibrillation (Afib). Afib patients are at increased risk for certain types of serious medical conditions related to clotting disorders. When an Afib patient in not properly medicated, he or she is more likely to develop large and dangerous blood clots deep within his or her veins.

These clots can develop deep within the legs and break loose, causing a medical condition known as deep vein thrombosis (DVT). A DVT clot can then travel through the body’s circulatory system until it reaches a vital organ. The clot can puncture the lung, causing a pulmonary embolism (PE), which is often fatal to victims. Additionally, the clots can block the blood supply to the brain, causing the brain to be deprived of oxygen-rich blood and resulting in a stroke. Continue reading

July 15, 2015

Studies on Using Pradaxa and Xarelto During Surgery

by Jeffrey S. Glassman

Pradaxa, Xarelto, and Eliquis are all members of a relatively new class of drugs known as new oral anticoagulants (NOACs). These drugs were designed for patients who suffer from a medical condition known as atrial fibrillation (Afib). Afib patients need a blood thinning medication to prevent deep vein clots from forming.

A deep vein clot can form a serous medical condition known as Deep Vein Thrombosis (DVT), where the clot forms in the veins of the legs and then breaks loose and travels though the blood system, where it can do serious damage. If the clot blocks the flow of blood to the brain, the patient will suffer a stroke, which can result in permanent injury or death. If the clot enters the lungs, it can puncture the pleural membrane, causing a serious internal bleeding condition known as a pulmonary embolism (PE). Continue reading